GLP-1 Weight Loss in Providence (2026)

172 GLP-1 telehealth providers ship to Providence, Rhode Island. Compounded semaglutide averages $219/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Featured Partners · Providence

Featured GLP-1 providers serving Providence

No insurance needed
reader-supported

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Top pick
7.1
MEDVi
Compounded from
$179/mo
Save $1,170/mo vs Wegovy
Get started →
7.4
Brightmeds
Compounded from
$100/mo
Save $986/mo vs Zepbound
Get started →
7.6
Maximus
Compounded from
$249.99/mo
Save $1,099.01/mo vs Wegovy
Get started →
8.3
Found
Compounded from
$99/mo
Save $1,250/mo vs Wegovy
Get started →
6.2
Wellorithm
Compounded from
$147/mo
Save $1,202/mo vs Wegovy
Get started →
7.8
Embody
Compounded from
$79/mo
Save $1,270/mo vs Wegovy
Get started →

Provider	Compounded from	Save vs brand
7.1MEDViTop pick	$179/mo	Save $1,170/mo	Get started →
7.4Brightmeds	$100/mo	Save $986/mo	Get started →
7.6Maximus	$249.99/mo	Save $1,099.01/mo	Get started →
8.3Found	$99/mo	Save $1,250/mo	Get started →
6.2Wellorithm	$147/mo	Save $1,202/mo	Get started →
7.8Embody	$79/mo	Save $1,270/mo	Get started →

See all 172 GLP-1 providers serving Providence ↓

Providence at a Glance

Providence population

190,934

City proper

Metro-area population

1,676,579

Wider telehealth market

Rhode Island obesity rank

#35 of 50

1 = highest prevalence

Rhode Island avg. compounded price

$219/mo

Semaglutide, cash-pay

About GLP-1 Access in Providence

Providence is a major city in Rhode Island with a population of approximately 190,934 residents. Telehealth is legal in Rhode Island, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Providence ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The greater Providence metro area is home to roughly 1,676,579 residents — one of the larger telehealth markets in Rhode Island, even though the city proper is smaller.

Rhode Island's adult obesity rate is approximately 31.6% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. Rhode Island ranks #35 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Providence residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

Rhode Island Medicaid covers GLP-1s for obesity with prior authorization, so Providence residents on Medicaid should start by asking their prescriber to document a qualifying BMI and comorbidities for the PA request.

Looking beyond Providence? See all GLP-1 providers in Rhode Island, or read our Rhode Island Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

Semaglutide in Providence

Best providers, pricing, and how to get started.

Tirzepatide in Providence

Best providers, pricing, and how to get started.

All GLP-1 Providers Serving Providence

CoreAge Rx

Verified partner

Best for: best overall value

8.3

CoreAge Rx offers LegitScript-certified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.

Score Breakdown

Value25%

8.5

Effectiveness25%

8.5

User Experience15%

8.5

Trust & Safety15%

7.8

Accessibility10%

Support10%

8.4

Pros

✓LegitScript certified — rigorous pharmacy standards
✓Free 2-day shipping nationwide
✓Both semaglutide and tirzepatide available
✓Lowest per-month pricing in the compounded segment
✓24/7 support team
✓All 50 states covered

Cons

✗Compounded only — no brand-name Ozempic or Wegovy
✗Newer brand with fewer independent reviews than legacy players

Starting from $99/moRead full review →

Visit CoreAge Rx →

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.2

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).

Score Breakdown

Value25%

Effectiveness25%

User Experience15%

8.5

Trust & Safety15%

Accessibility10%

8.5

Support10%

8.9

Pros

✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
✓Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
✓Unlimited clinician messaging and dose-adjustment support included

Cons

✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
✗No insurance accepted — cash pay, HSA/FSA eligible
✗Intro discount applies only to the first order — ongoing rates are $212–$322/mo on 12-month plans, or $249–$379/mo month-to-month

Starting from $112/moRead full review →

Visit Enhance MD →

Gala

Verified partner

Best for: compounded GLP-1/GIP combo on a yearly plan with free shipping

8.2

Gala (legal entity AI Coaching Inc., d/b/a Gala GLP-1) is a Delaware-incorporated telehealth platform selling compounded GLP-1/GIP (tirzepatide) on a yearly subscription, a lower-priced microdosing version of the same protocol, and brand-name Ozempic. It does not sell a compounded semaglutide product. The marketing site claims licensed providers in all 50 states with free shipping included. An oral Wegovy pill option is listed as 'coming soon.'

Score Breakdown

Value25%

8.5

Effectiveness25%

8.5

User Experience15%

Trust & Safety15%

7.3

Accessibility10%

Support10%

8.4

Pros

✓Compounded semaglutide and tirzepatide at $179/mo with all doses included on the yearly plan
✓Lower microdosing tirzepatide tier at $149/mo for a sub-therapeutic starting protocol
✓Brand-name Ozempic available alongside compounded options
✓Claims licensed providers in all 50 states with free shipping included
✓24/7 support, provider visit included, cancel anytime
✓LegitScript certified

Cons

✗$179/mo requires a yearly subscription — the standalone monthly price isn't published
✗Brand-name Ozempic at $1,299/mo is higher than peers (e.g., Found at $1,100/mo)
✗Pharmacy partners not named — only a "network of pharmacies" reference
✗Wegovy oral pill listed as "coming soon," not yet available
✗Per-state availability isn't listed; the all-50-states claim is gated behind intake

Starting from $149/moRead full review →

Visit Gala →

bmiMD

Verified partner

Best for: mainstream telehealth GLP-1 access

8.1

Medical weight loss clinic offering GLP-1 prescriptions through telehealth.

Score Breakdown

Value25%

Effectiveness25%

User Experience15%

7.5

Trust & Safety15%

7.3

Accessibility10%

8.5

Support10%

Pros

✓Both semaglutide and tirzepatide available

Cons

✗Cheapest advertised rates require a 12-month prepaid plan — month-to-month is $129 for semaglutide and $139 for sermorelin injection

Starting from $99/moRead full review →

Visit bmiMD →

RxSpan MD

Verified partner

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

8.1

RxSpan MD is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon, offering compounded GLP-1 weight loss — semaglutide and tirzepatide from $249/mo, as injections or oral capsules — plus brand-name Wegovy, Zepbound and Ozempic. It's unusually transparent: it names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group, ships free, and includes unlimited 24/7 support. Available in all 50 states.

Score Breakdown

Value25%

Effectiveness25%

8.5

User Experience15%

7.5

Trust & Safety15%

9.3

Accessibility10%

8.5

Support10%

8.9

Pros

✓Physician-led — founded by Dr. John Diaz, a board-certified plastic surgeon with 20+ years' experience
✓Compounded semaglutide and tirzepatide from $249/mo (injection or oral capsules), plus brand-name Wegovy, Zepbound and Ozempic
✓Names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group
✓LegitScript-certified (#50405601); free expedited shipping and unlimited 24/7 support included
✓Available in all 50 states via a 2-minute assessment

Cons

✗Compounded pricing ($249 semaglutide / $329 tirzepatide) sits mid-to-high versus the cheapest telehealth options
✗Brand-name GLP-1 is priced steeply (Wegovy $1,349, Ozempic $1,299, Zepbound $1,069)
✗Multi-vertical practice (also hair, sexual health, longevity), not weight-loss-only
✗You pay at checkout before a clinician reviews you, and the site says a prescription is not guaranteed

Editorial score · methodology

$219/mosemaglutide

$299/motirzepatide

CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified

Get Started Read full MadeMed review →

Browse all 341 providers with undisclosed coverage on the Rhode Island page →

In-Person vs Telehealth in Providence

Patients in Providence have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Rhode Island addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Rhode Island varies by plan^[4].

In-person weight-management clinics in Providence (39 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism.

Alicia Warnock — Endocrinology, Diabetes & Metabolism, 830 Chalkstone Ave
Charles Kahn — Endocrinology, Diabetes & Metabolism, 49 Seekonk St
Daryl Selen — Endocrinology, Diabetes & Metabolism, 100 Dudley St
David Maclean — Endocrinology, Diabetes & Metabolism, 1 Hoppin St
Diabetes & Endocrinology Associates, Inc. — Endocrinology, Diabetes & Metabolism, 100 Highland Ave
Ivana Lukacova-Zib — Endocrinology, Diabetes & Metabolism, 1 Hoppin St
Joseph Tucci — Endocrinology, Diabetes & Metabolism, 50 Maude St
Maged Taman — Endocrinology, Diabetes & Metabolism, 21 Peace Street

Browse all 39 Providence clinics in the directory →

Cost of GLP-1 Medications in Providence

Average compounded semaglutide (Rhode Island)^[1]

$219/month

Brand-name Wegovy in Providence typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $219/month in Rhode Island, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Frequently Asked Questions

Providence residents can get GLP-1 medications through licensed telehealth providers that ship compounded semaglutide or tirzepatide directly to Rhode Island addresses, or by seeing a local clinician in person and filling a brand-name prescription (Wegovy, Zepbound, Ozempic, Mounjaro) at a retail pharmacy. Telehealth providers that serve Rhode Island are listed above, and our directory tracks 39 in-person weight-management clinics in Providence itself.

Yes. Our clinic directory lists 39 weight-management practices in Providence, RI, drawn from the NPI registry and matched on obesity-medicine, bariatric, and related taxonomy codes — most commonly endocrinology, diabetes & metabolism. In-person care is usually the better path when insurance covers a brand-name GLP-1 and requires documented visits; the ranked telehealth list above is usually the cheaper cash-pay path.

Yes — telehealth prescribing of GLP-1 medications is legal in Rhode Island. Licensed providers can conduct an online evaluation, prescribe semaglutide or tirzepatide when clinically appropriate, and arrange delivery to your address through a partner pharmacy.

Compounded semaglutide pricing is set at the provider level, not the city level, and varies by dose and plan. See the pricing columns on each provider card above for the current monthly cost from providers that serve Rhode Island. Brand-name Wegovy and Zepbound retail list prices are $1,000-$1,350 per month without insurance.

Insurance coverage in Providence follows Rhode Island plan-level rules. Most commercial plans cover Ozempic and Mounjaro for type 2 diabetes diagnoses, but coverage for Wegovy and Zepbound (the obesity-indicated versions) is much more limited and typically requires prior authorization. Check your plan's formulary for the specific drug and indication you need.

The lowest-cost route for Providence residents is usually compounded semaglutide or tirzepatide through telehealth, averaging around $219/month in Rhode Island — well below brand-name Wegovy ($1,349/mo) or Zepbound ($1,086/mo) without insurance. Compare current pricing from providers serving Providence above, or check if your insurance covers a brand-name option first.

Rhode Island Medicaid coverage for GLP-1 weight-loss medication is currently: Diabetes + obesity (with prior auth). Ozempic and Mounjaro are generally covered for type 2 diabetes, while the obesity-indicated versions (Wegovy, Zepbound) typically require prior authorization or aren't covered at all, depending on the plan.

172 GLP-1 telehealth and in-person providers currently serve Providence residents, based on our tracked pricing and availability data. See the full ranked list above, or browse the A-Z index for every provider that ships to Rhode Island.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Semaglutide · Drugs and brands
Tirzepatide · Drugs and brands
Compounded GLP-1 · Pharmacy and drug forms
503A pharmacy · Pharmacy and drug forms
PCAB accreditation · Pharmacy and drug forms
Prior authorization (PA) · Insurance and regulatory
Off-label use · Insurance and regulatory
FDA Drug Shortage List · Insurance and regulatory

Compare All Providers Calculate Savings

Get Providence Price Alerts

Be the first to know about new GLP-1 providers and price changes in Providence.

Sources & methodology — as of October 2026

1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.